Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Interest Expenses (2023 - 2025)

Bioregenx has reported Interest Expenses over the past 3 years, most recently at $82147.0 for Q4 2025.

  • For Q4 2025, Interest Expenses fell 1.92% year-over-year to $82147.0; the TTM value through Dec 2025 reached $299578.0, up 3.07%, while the annual FY2025 figure was $299578.0, 3.07% up from the prior year.
  • Interest Expenses for Q4 2025 was $82147.0 at Bioregenx, up from $72106.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $83756.0 in Q4 2024 and troughed at $45193.0 in Q4 2023.
  • A 3-year average of $65124.2 and a median of $69319.5 in 2024 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: skyrocketed 85.33% in 2024 and later dropped 1.92% in 2025.
  • Year by year, Interest Expenses stood at $45193.0 in 2023, then skyrocketed by 85.33% to $83756.0 in 2024, then dropped by 1.92% to $82147.0 in 2025.
  • Business Quant data shows Interest Expenses for BRGX at $82147.0 in Q4 2025, $72106.0 in Q3 2025, and $71086.0 in Q2 2025.